The invention provides compounds of Formula I: ##STR00001## where in W is ##STR00002## These compounds may be in the form of pharmaceutical salts or compositions, racemic mixtures, or pure enantiomers thereof. The compounds of Formula I are useful to treat diseases or conditions in which .alpha.7 is known to be involved.

 
Web www.patentalert.com

< PN7718 nucleic acids and use thereof

< Betaines as adjuvants to susceptibility testing and antimicrobial therapy

> Zinc finger binding domains for nucleotide sequence ANN

> Targeting cellular entry, cell survival, and pathogenicity by dynein light chain 1/PIN in human cells

~ 00273